Form 483

UNIVERSITY OF CALIFORNIA, LOS ANGELES Form 483, 2016-06-02

FDA issued a Form 483 to UNIVERSITY OF CALIFORNIA, LOS ANGELES on 2016-06-02 with 7 public-safe observations.

483· Form 483 issuedHuman Drugs7 observations

UNIVERSITY OF CALIFORNIA, LOS ANGELES · Los Angeles, United States · Issued June 2, 2016

Overview

  • 7 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

2 Jun 2016
21 CFR 212.20(d)

Determination need for investigation

Cited by Djamila Harouaka

2 Jun 2016
21 CFR 212.20(e)

Written QA procedures established, followed

Cited by Djamila Harouaka

2 Jun 2016
21 CFR 212.40(d)

Contamination, mix-ups and deterioration

Cited by Djamila Harouaka

2 Jun 2016
21 CFR 212.50(b)(7)

Complete instructions, procedures, specs

Cited by Djamila Harouaka

2 Jun 2016
21 CFR 212.50(c)(11)

Results of investigations

Cited by Djamila Harouaka

Inspected site

UOUNIVERSITY OF CALIFORNIA, LOS ANGELESLos Angeles, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 212.60(g)(3)Cited across public-safe Form 483 observations2x
21 CFR 212.20(d)Cited across public-safe Form 483 observations1x
21 CFR 212.20(e)Cited across public-safe Form 483 observations1x
21 CFR 212.40(d)Cited across public-safe Form 483 observations1x
21 CFR 212.50(b)(7)Cited across public-safe Form 483 observations1x
21 CFR 212.50(c)(11)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 7 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere